Martin Brenner
CIK 1770235 · View on SEC EDGAR ↗
First SEC filing: Jan. 19, 2021 · Latest: Jan. 19, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | IBIO | P | 12,336 | $2.02 | $24,919 | 30,652 Direct | +67.35% | Acquired | -28.2% (price as of 2026-08-20) |
| Jan. 10, 2025 | IBIO | P | 9,191 | $2.72 | $25,000 | 18,316 Direct | +100.72% | Acquired | -46.7% (price as of 2026-08-20) |
| Nov. 1, 2023 | IBIO | S | 4,881 | $0.27 | $1,318 | 182,502 Direct | -2.60% | Disposed | -73.1% (price as of 2026-08-20) |
| Oct. 3, 2023 | IBIO | S | 5,267 | $0.30 | $1,580 | 187,383 Direct | -2.73% | Disposed | -75.8% (price as of 2026-08-20) |
| Oct. 2, 2023 | IBIO | S | 4,215 | $0.31 | $1,307 | 192,650 Direct | -2.14% | Disposed | -76.6% (price as of 2026-08-20) |
| Aug. 28, 2023 | IBIO | S | 5,011 | $0.31 | $1,553 | 196,865 Direct | -2.48% | Disposed | -76.6% (price as of 2026-08-20) |
| July 27, 2023 | IBIO | S | 35 | $0.51 | $18 | 201,876 Direct | -0.02% | Disposed | -85.8% (price as of 2026-08-20) |
| July 27, 2023 | IBIO | S | 4,480 | $0.51 | $2,285 | 201,911 Direct | -2.17% | Disposed | -85.8% (price as of 2026-08-20) |
| July 12, 2023 | IBIO | S | 47,020 | $0.59 | $27,742 | 206,391 Direct | -18.55% | Disposed | -87.7% (price as of 2026-08-20) |
| June 21, 2023 | IBIO | S | 100 | $0.68 | $68 | 253,411 Direct | -0.04% | Disposed | -89.3% (price as of 2026-08-20) |
| June 21, 2023 | IBIO | S | 225 | $0.69 | $155 | 253,511 Direct | -0.09% | Disposed | -89.5% (price as of 2026-08-20) |
| June 21, 2023 | IBIO | S | 3,859 | $0.68 | $2,624 | 253,736 Direct | -1.50% | Disposed | -89.3% (price as of 2026-08-20) |
| May 22, 2023 | IBIO | S | 24 | $0.94 | $23 | 257,595 Direct | -0.01% | Disposed | -92.3% (price as of 2026-08-20) |
| May 22, 2023 | IBIO | S | 4,158 | $0.94 | $3,909 | 257,619 Direct | -1.59% | Disposed | -92.3% (price as of 2026-08-20) |
| April 24, 2023 | IBIO | S | 4,382 | $1.20 | $5,258 | 261,777 Direct | -1.65% | Disposed | -94.0% (price as of 2026-08-20) |
| March 23, 2023 | IBIO | S | 5,213 | $2.13 | $11,104 | 216,159 Direct | -2.35% | Disposed | -96.6% (price as of 2026-08-20) |
| Feb. 21, 2023 | IBIO | S | 3,976 | $1.77 | $7,038 | 221,372 Direct | -1.76% | Disposed | -95.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | IBIO | Stock Option (right to buy) [F1] | Common Stock (479,000) | $2.23 | Jan. 27, 2036 | 479,000 | Acquired |
| Oct. 20, 2025 | IBIO | Stock Option (right to buy) [F1] | Common Stock (180,000) | $0.89 | Oct. 19, 2035 | 180,000 | Acquired |
| Feb. 21, 2025 | IBIO | Stock Option (right to buy) [F1] | Common Stock (230,700) | $3.48 | Feb. 20, 2035 | 230,700 | Acquired |
| May 9, 2024 | IBIO | Stock Option (right to buy) [F1] | Common Stock (110,000) | $1.88 | May 9, 2034 | 110,000 | Acquired |
| May 9, 2024 | IBIO | Stock Option (right to buy) [F1] | Common Stock (147,300) | $1.88 | May 9, 2034 | 147,300 | Acquired |
| Aug. 23, 2023 | IBIO | Stock Option (right to buy) [F1] | Common Stock (120,000) | $0.35 | Aug. 23, 2033 | 120,000 | Acquired |
| Aug. 29, 2022 | IBIO | Stock Option (right to buy) [F1] | Common Stock (700,000) | $0.28 | Aug. 29, 2032 | 700,000 | Acquired |
| Aug. 23, 2021 | IBIO | Stock Option (right to buy) [F1] | Common Stock (700,000) | $1.26 | Aug. 22, 2031 | 700,000 | Acquired |
| Jan. 18, 2021 | IBIO | Stock Option | Common Stock (500,000) | $1.47 | Jan. 18, 2031 | 500,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $405,000 | — | — | — | — | — | — | $1,336,189 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.